United Therapeutics Corp (NAS:UTHR)
$ 360.87 -2.78 (-0.76%) Market Cap: 16.11 Bil Enterprise Value: 13.18 Bil PE Ratio: 15.85 PB Ratio: 2.64 GF Score: 86/100

Q3 2023 United Therapeutics Corp Earnings Call Transcript

Nov 01, 2023 / 01:00PM GMT
Release Date Price: $224.08 (+0.55%)
Operator

Good morning, and welcome to the United Therapeutics Corporation Third Quarter 2023 Earnings Webcast. My name is Rafael and I will be your conference operator today. (Operator Instructions) Please note, this call is being recorded.

I will now turn the webcast over to Dewey Steadman, Head of Investor Relations, United Therapeutics. Please go ahead.

Dewey Steadman
United Therapeutics Corporation - Head of IR

Thank you, Rafael, and good morning, everyone. It's my pleasure to welcome you to the United Therapeutics Third Quarter 2023 Earnings Webcast. Accompanying me today -- accompanying me today are Dr. Martine Rothblatt, our Chairperson and Chief Executive Officer; Michael Benkowitz, our President and Chief Operating Officer; James Edgemond, our Chief Financial Officer and Treasurer; Pat Poisson, our Executive Vice President of Technical Operations; and Dr. Leigh Peterson, our Executive Vice President of Product Development and Xenotransplantation.

Remarks today will include forward-looking statements representing our expectations or beliefs

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot